APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

DNA Vaccines

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Selected research

Industry Growth & Trends

Global DNA Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173985400119 December 202596 pages

Choose your research edition.

Industry ResearchDNA Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Vaccines Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal DNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global DNA Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The DNA Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global DNA Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to DNA Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global DNA Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

DNA Vaccines Market by Company

Merck

GSK

Sanofi

Zoties

Elanco

Boehringer-Ingelheim

Indian Immunologicals

Plumbline Life Sciences

DNA Vaccines Segment by Type

Recombinant Protein Vaccine

Gene-Based Vaccine

DNA Vaccines Segment by Application

Human

Animal

DNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of DNA Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Protein Vaccine Table 2. Major Company of Gene-Based Vaccine Table 3. Global DNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 5. Global DNA Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global DNA Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global DNA Vaccines Price by Type (2021-2026) & (US$/Dose) Table 9. Global DNA Vaccines Sales by Type (2027-2032) & (K Doses) Table 10. Global DNA Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global DNA Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global DNA Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global DNA Vaccines Price by Type (2027-2032) & (US$/Dose) Table 14. North America DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 15. North America DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 17. Europe DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 19. Asia-Pacific DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 21. Latin America DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa DNA Vaccines Sales by Type (2021-2026) & (K Doses) Table 23. Middle East and Africa DNA Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. DNA Vaccines Industry Trends Table 25. DNA Vaccines Industry Drivers Table 26. DNA Vaccines Industry Opportunities and Challenges Table 27. DNA Vaccines Industry Restraints Table 28. Global DNA Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global DNA Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global DNA Vaccines Sales by Company (2021-2026) & (K Doses) Table 31. Global DNA Vaccines Sales Share by Company (2021-2026) Table 32. Global DNA Vaccines Market Price by Company (2021-2026) & (US$/Dose) Table 33. Global DNA Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global DNA Vaccines Major Company Production Sites and Headquarters Table 35. Global DNA Vaccines Company, Product Type & Application Table 36. Global DNA Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global DNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global DNA Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global DNA Vaccines Sales by Region (2021-2026) & (K Doses) Table 41. Global DNA Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global DNA Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global DNA Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global DNA Vaccines Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 45. Global DNA Vaccines Sales by Region (2027-2032) & (K Doses) Table 46. Global DNA Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global DNA Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global DNA Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global DNA Vaccines Sales (K Doses), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 50. Global DNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 52. Global DNA Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global DNA Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global DNA Vaccines Price by Application (2021-2026) & (US$/Dose) Table 56. Global DNA Vaccines Sales by Application (2027-2032) & (K Doses) Table 57. Global DNA Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global DNA Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global DNA Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global DNA Vaccines Price by Application (2027-2032) & (US$/Dose) Table 61. North America DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 62. North America DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 64. Europe DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 66. Asia-Pacific DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 68. Latin America DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa DNA Vaccines Sales by Application (2021-2026) & (K Doses) Table 70. Middle East and Africa DNA Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. Merck DNA Vaccines Product Portfolio Table 75. Merck Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. GSK DNA Vaccines Product Portfolio Table 80. GSK Recent Development Table 81. Sanofi Company Information Table 82. Sanofi Business Overview Table 83. Sanofi DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. Sanofi DNA Vaccines Product Portfolio Table 85. Sanofi Recent Development Table 86. Zoties Company Information Table 87. Zoties Business Overview Table 88. Zoties DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 89. Zoties DNA Vaccines Product Portfolio Table 90. Zoties Recent Development Table 91. Elanco Company Information Table 92. Elanco Business Overview Table 93. Elanco DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 94. Elanco DNA Vaccines Product Portfolio Table 95. Elanco Recent Development Table 96. Boehringer-Ingelheim Company Information Table 97. Boehringer-Ingelheim Business Overview Table 98. Boehringer-Ingelheim DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 99. Boehringer-Ingelheim DNA Vaccines Product Portfolio Table 100. Boehringer-Ingelheim Recent Development Table 101. Indian Immunologicals Company Information Table 102. Indian Immunologicals Business Overview Table 103. Indian Immunologicals DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 104. Indian Immunologicals DNA Vaccines Product Portfolio Table 105. Indian Immunologicals Recent Development Table 106. Plumbline Life Sciences Company Information Table 107. Plumbline Life Sciences Business Overview Table 108. Plumbline Life Sciences DNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 109. Plumbline Life Sciences DNA Vaccines Product Portfolio Table 110. Plumbline Life Sciences Recent Development Table 111. North America DNA Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 112. North America DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 113. North America DNA Vaccines Sales Market Share by Country (2021-2026) Table 114. North America DNA Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 115. North America DNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. North America DNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America DNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. North America DNA Vaccines Market Share by Country (2021-2026) Table 119. North America DNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America DNA Vaccines Market Share Forecast by Country (2027-2032) Table 121. Europe DNA Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 122. Europe DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 123. Europe DNA Vaccines Sales Market Share by Country (2021-2026) Table 124. Europe DNA Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 125. Europe DNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Europe DNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe DNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe DNA Vaccines Market Share by Country (2021-2026) Table 129. Europe DNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe DNA Vaccines Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific DNA Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 133. Asia-Pacific DNA Vaccines Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific DNA Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 135. Asia-Pacific DNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific DNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific DNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific DNA Vaccines Market Share by Country (2021-2026) Table 139. Asia-Pacific DNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific DNA Vaccines Market Share Forecast by Country (2027-2032) Table 141. Latin America DNA Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 142. Latin America DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 143. Latin America DNA Vaccines Sales Market Share by Country (2021-2026) Table 144. Latin America DNA Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 145. Latin America DNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America DNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America DNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America DNA Vaccines Market Share by Country (2021-2026) Table 149. Latin America DNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America DNA Vaccines Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa DNA Vaccines Market Size Growth Rate (CAGR) by Country (K Doses): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa DNA Vaccines Sales by Country (2021-2026) & (K Doses) Table 153. Middle East and Africa DNA Vaccines Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa DNA Vaccines Sales Forecast by Country (2027-2032) & (K Doses) Table 155. Middle East and Africa DNA Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa DNA Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa DNA Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa DNA Vaccines Market Share by Country (2021-2026) Table 159. Middle East and Africa DNA Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa DNA Vaccines Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. DNA Vaccines Distributors List Table 164. DNA Vaccines Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. DNA Vaccines Image Figure 2. Global DNA Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Vaccines Sales (2021-2032) & (K Doses) Figure 5. Recombinant Protein Vaccine Image Figure 6. Global Recombinant Protein Vaccine Sales YoY Growth (2021-2032) & (K Doses) Figure 7. Gene-Based Vaccine Image Figure 8. Global Gene-Based Vaccine Sales YoY Growth (2021-2032) & (K Doses) Figure 9. Global DNA Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global DNA Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America DNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America DNA Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe DNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe DNA Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific DNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific DNA Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America DNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America DNA Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa DNA Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa DNA Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Human Image Figure 24. Global Human Sales YoY Growth (2021-2032) & (K Doses) Figure 25. Animal Image Figure 26. Global Animal Sales YoY Growth (2021-2032) & (K Doses) Figure 27. Global DNA Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global DNA Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America DNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America DNA Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe DNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe DNA Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific DNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific DNA Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America DNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America DNA Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa DNA Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa DNA Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America DNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 40. North America DNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America DNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe DNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 44. Europe DNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe DNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific DNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 48. Asia-Pacific DNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific DNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America DNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 52. Latin America DNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America DNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa DNA Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Doses) Figure 56. Middle East and Africa DNA Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa DNA Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa DNA Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. DNA Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. DNA Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Protein Vaccine
  • Gene-Based Vaccine
Applications
  • Human
  • Animal
Companies covered
  • Merck
  • GSK
  • Sanofi
  • Zoties
  • Elanco
  • Boehringer-Ingelheim
  • Indian Immunologicals
  • Plumbline Life Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DNA Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global DNA Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 DNA Vaccines Market by Type
  6. 1.3.1 Recombinant Protein Vaccine
  7. 1.3.2 Gene-Based Vaccine
  8. 1.4 Global DNA Vaccines Market Size by Type
  9. 1.4.1 Global DNA Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global DNA Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global DNA Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America DNA Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe DNA Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific DNA Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America DNA Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa DNA Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 DNA Vaccines Industry Trends
  2. 2.2 DNA Vaccines Industry Drivers
  3. 2.3 DNA Vaccines Industry Opportunities and Challenges
  4. 2.4 DNA Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by DNA Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by DNA Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by DNA Vaccines Price (2021-2026)
  4. 3.4 Global DNA Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global DNA Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global DNA Vaccines Company, Product Type & Application
  7. 3.7 Global DNA Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global DNA Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 DNA Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 DNA Vaccines Tier 1, Tier 2, and Tier 3
4 DNA Vaccines Regional Status and Outlook
  1. 4.1 Global DNA Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global DNA Vaccines Historic Market Size by Region
  3. 4.2.1 Global DNA Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global DNA Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global DNA Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global DNA Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global DNA Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global DNA Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global DNA Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 DNA Vaccines by Application
  1. 5.1 DNA Vaccines Market by Application
  2. 5.1.1 Human
  3. 5.1.2 Animal
  4. 5.2 Global DNA Vaccines Market Size by Application
  5. 5.2.1 Global DNA Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global DNA Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global DNA Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America DNA Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe DNA Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific DNA Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America DNA Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa DNA Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck DNA Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK DNA Vaccines Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi DNA Vaccines Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Zoties
  20. 6.4.1 Zoties Company Information
  21. 6.4.2 Zoties Business Overview
  22. 6.4.3 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zoties DNA Vaccines Product Portfolio
  24. 6.4.5 Zoties Recent Developments
  25. 6.5 Elanco
  26. 6.5.1 Elanco Company Information
  27. 6.5.2 Elanco Business Overview
  28. 6.5.3 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Elanco DNA Vaccines Product Portfolio
  30. 6.5.5 Elanco Recent Developments
  31. 6.6 Boehringer-Ingelheim
  32. 6.6.1 Boehringer-Ingelheim Company Information
  33. 6.6.2 Boehringer-Ingelheim Business Overview
  34. 6.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Boehringer-Ingelheim DNA Vaccines Product Portfolio
  36. 6.6.5 Boehringer-Ingelheim Recent Developments
  37. 6.7 Indian Immunologicals
  38. 6.7.1 Indian Immunologicals Company Information
  39. 6.7.2 Indian Immunologicals Business Overview
  40. 6.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Indian Immunologicals DNA Vaccines Product Portfolio
  42. 6.7.5 Indian Immunologicals Recent Developments
  43. 6.8 Plumbline Life Sciences
  44. 6.8.1 Plumbline Life Sciences Company Information
  45. 6.8.2 Plumbline Life Sciences Business Overview
  46. 6.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Plumbline Life Sciences DNA Vaccines Product Portfolio
  48. 6.8.5 Plumbline Life Sciences Recent Developments
7 North America by Country
  1. 7.1 North America DNA Vaccines Sales by Country
  2. 7.1.1 North America DNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America DNA Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America DNA Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America DNA Vaccines Market Size by Country
  6. 7.2.1 North America DNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America DNA Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America DNA Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe DNA Vaccines Sales by Country
  2. 8.1.1 Europe DNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe DNA Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe DNA Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe DNA Vaccines Market Size by Country
  6. 8.2.1 Europe DNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe DNA Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe DNA Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific DNA Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific DNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific DNA Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific DNA Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific DNA Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific DNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific DNA Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific DNA Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America DNA Vaccines Sales by Country
  2. 10.1.1 South America DNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America DNA Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America DNA Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America DNA Vaccines Market Size by Country
  6. 10.2.1 South America DNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America DNA Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America DNA Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa DNA Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa DNA Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa DNA Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa DNA Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa DNA Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa DNA Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa DNA Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa DNA Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 DNA Vaccines Value Chain Analysis
  2. 12.1.1 DNA Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 DNA Vaccines Production Mode & Process
  7. 12.2 DNA Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 DNA Vaccines Distributors
  10. 12.2.3 DNA Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst